Rivia
Unified Intelligence Layer for Clinical Trials
Zurich, Switzerland · $15.0M raised
- Total Funding
- $15.0M
- Last Round
- $15.0M Series AMar 2026
- Rounds
- 2
About
AI-powered data analytics platform unifying clinical trial data for biopharma companies.
Summary
Rivia is a Biotech company based in Zurich, Switzerland. It has raised $15.0M in total across 2 rounds, most recently a $15.0M Series A round in Mar 2026. Investors include Speedinvest, Earlybird Venture Capital and Nina Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2026
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rivia"><img src="https://indexed.vc/api/badge/company/rivia" alt="Rivia on Indexed.vc" width="260" height="76" /></a>